Healthy lifestyle promotion program including vaccination for dyads of seniors and their companions: A randomized trial
Methods: From April 2011 to February 2014, the trial involved 235 dyads (117 HDP; 118 ACP). The data come from pre and 6-month post-intervention questionnaires that included items on participants’ influenza, zoster and pneumococcal vaccine status.
Results: Baseline vaccine status did not differ between the HDP and ACP groups, for both seniors and companions. At baseline, proportions of seniors who had received the influenza, zoster and pneumococcal vaccine were 63.8%, 2.1% and 65.5%, respectively. Figures for companions were 58.7%, 2.5% and 42.5%. None of the Group-by-Time interactions were significant (all ps>0.20). Pre-post comparisons in the HDP groups revealed a significant increase in the proportions of seniors vaccinated against influenza (from 62.4% to 68.9%, p=0.040) and of companions vaccinated against zoster (from 2.6% to 4.4%, p=0.046). No differences were significant in the ACP group.
Conclusion: These data suggest that only negligible gains had been made with the HDP. The HDP should be reviewed if vaccine coverage improvement is targeted.
Learning Areas:Conduct evaluation related to programs, research, and other areas of practice
Implementation of health education strategies, interventions and programs
Public health or related education
Public health or related research
Evaluate the efficacy of an intervention promoting a healthy lifestyle which includes immunization targeting dyads of seniors and their companions.
Keyword(s): Aging, Immunizations
Qualified on the content I am responsible for because: I have been the principal or co-principal of multiple publicly funded grants in Quebec, Canada focusing on program evaluation and immunization program evaluation. I am member of the Quebec Immunization Committee which is responsible for counselling the Quebec Ministry of Health on immunization programs.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.